Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok3. fázis

SMART Exercise for PAD

A legfontosabb adatok

Ki végzi
Northwestern University
Hol
Chicago és Minneapolis (Egyesült Államok)Mind a 3 helyszín megnézése
Azonosító
Állapot
Toboroz
Fázis
3. fázis
Résztvevők
210 fő, tervezett
Kezdés
2023. szept. 8.
Várható befejezés
2029. márc. 31.
A vizsgálat típusa
Beavatkozással járó, 4 csoportAz egyik csoport placebót (hatóanyag nélküli szert) kap, összehasonlításként.
A vizsgált kezelések
  • Supervised Treadmill Exercise
  • Home-Based Exercise
  • Nitrate-rich beetroot Juice
A regiszteradat frissítve
2026. április 15.

Ki vehet részt

The trial is looking for people aged 50 and older with peripheral artery disease (PAD), narrowed leg arteries. It tests supervised or home walking exercise with nitrate-rich beetroot juice or a placebo drink.

Életkor
50 Years and older
Nem
All sexes
A betegség stádiuma
PAD shown by an ABI <= 0.90, or vascular lab tests (toe brachial pressure <= 0.70), or at least 70% narrowing of a leg artery on imaging, or an ABI >0.90 and <1.00 with a 20% or greater drop after a heel-rise test.
Korábbi kezelés
No supervised treadmill exercise or cardiac rehabilitation in the previous three months. No major surgery, heart or leg artery procedure in the previous three months. Not already exercising at the study's level.
Biomarker vagy leletérték
Ankle brachial index (ABI) as described. Cannot join with eGFR <30 or potassium >5.0.
A részvétel fő kizáró okai
  • Leg amputation, foot ulcer on the bottom of the foot, or severe leg blood flow loss (ABI <0.40 with rest pain)
  • Using a wheelchair or walker, or walking limited by something other than PAD
  • Kidney disease needing dialysis, or kidney stones needing low oxalate intake
  • Unwilling to drink beetroot juice, beetroot allergy, or already taking beetroot or nitrate supplements
  • Unstable angina, dementia, or not speaking English
A regiszter összes feltétele (31)A regiszter feltételeinek elrejtése

Ki vehet részt

  • First, all participants will be age 50 and older. Second, all participants will have PAD. PAD will be defined as either:
  • An ABI <= 0.90 at baseline
  • Vascular lab evidence of PAD (such as a toe brachial pressure less than or equal to 0.70 or an ankle brachial index less than or equal to 0.90), or angiographic evidence of PAD defined as at least 70% stenosis of an artery supplying the lower extremities
  • An ABI of >0.90 and <1.00 who experience a 20% or greater drop in ABI in either leg after the heel-rise test

Ki nem vehet részt

  • Planned major surgery, coronary or leg revascularization during the next six months
  • Major surgery, coronary or leg revascularization or major cardiovascular event in the previous three months
  • Major medical illness including lung disease requiring oxygen, Parkinson's disease, a life-threatening illness with life expectancy less than six months, or cancer requiring treatment in the previous two years. [NOTE: potential participants may still qualify if they have had treatment for an early stage cancer in the past two years and the prognosis is excellent. Participants who require oxygen only at night may still qualify.]
  • Currently consuming beetroot juice or oral nitrate or nitrite, or a beetroot supplement, and/or unwilling to avoid these during study participation. Participants currently consuming one cup of beets daily will be asked to discontinue beet ingestion for 30 days before baseline testing and throughout the clinical trial. If the potential participant is unwilling to refrain from daily beet consumption of one cup or more, they will not be eligible for the clinical trial
  • Participation in or completion of a clinical trial in the previous three months. [NOTE: after completing a stem cell or gene therapy intervention, participants will become eligible after the final study follow-up visit of the stem cell or gene therapy study so long as at least six months have passed since the final intervention administration. After completing a supplement or drug therapy (other than stem cell or gene therapy), participants will be eligible after the final study follow-up visit as long as at least three months have passed since the final intervention of the trial.] Participants in a study that involved up to three single doses of nitrate-rich beetroot juice administered on separate days may participate if a month has passed since their last dose of nitrate-rich beetroot juice
  • Participation in a supervised treadmill exercise program or cardiac rehabilitation program in previous three months
  • Walking is limited by a condition other than PAD
  • Current foot ulcer on bottom of foot
  • End-stage kidney disease (ESKD) associated with the need for dialysis
  • Mini-Mental Status Examination (MMSE) score < 23 or dementia. However, if the MMSE is < 23 and the Principal Investigator evaluation determines that the lower score is related to language barriers or education level, the Principal Investigator has discretion to allow a participant with MMSE < 23 to participate, as appropriate
  • Allergy to beetroot juice
  • Unstable angina
  • Visual impairment that limits walking ability
  • History of kidney stones that requires minimized intake of oxalate. Potential participants who need to minimize oxalate intake will be excluded from the trial
  • Abnormal baseline stress test without subsequent clearance for exercise by physician
  • An eGFR value <30 or potassium >5.0
  • Above- or below-knee amputation
  • Limb-threatening ischemia defined as an ABI <0.40 with symptoms of rest pain
  • Wheelchair confinement or requiring a walker to ambulate
  • Unwilling to drink beetroot juice
  • Unwilling to accept randomization into either group (home based exercise or supervised exercise)
  • Planning to engage in new walking exercise outside of the study or unwilling to refrain from new walking exercise activity during the trial
  • Already exercising at a level consistent with exercise intervention
  • Non-English speaking. The SMART PAD interventions are delivered by interventionists who do not speak non-English languages. The integrity of the clinical trial requires clear and effective communication for data collection and intervention delivery. The trial does not have staff members who are fluent in non-English languages, nor does it have the ability to translate all study materials into other languages
  • Baseline blood pressure <100/45
  • Using a mouthwash containing chlorhexidine or cetylpyridinium chloride or a mouthwash determined to be bactericidal and unwilling to discontinue
  • In addition to the above criteria, investigator discretion will be used to determine if the trial is unsafe or not a good fit for the potential participant

Alkalmassági kérdőív

Ez nem döntés: hogy ki vehet részt, azt csak a vizsgálat csapata mondhatja meg.

  • Életkor
  • Peripheral arterial disease vagy aging vagy peripheral vascular diseases

Ez a vizsgálat jelenleg itt érhető el: Egyesült Államok.

  • Northwestern University Feinberg School of MedicineChicago, Egyesült ÁllamokContact: Kathryn Domanchuk, BSRésztvevőt keres
  • University of ChicagoChicago, Egyesült ÁllamokContact: Tamar Polonsky, MDRésztvevőt keres
  • University of MinnesotaMinneapolis, Egyesült ÁllamokContact: Diane Treat-Jacobson, PhDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Supervised exercise therapy (SET), consisting of treadmill exercise conducted three times weekly at a center while supervised by healthcare personnel, is first line therapy for people disabled by lower extremity peripheral artery disease (PAD). However, travelling three times/week to a center for SET is burdensome. Compared to SET, home-based exercise is more accessible and less burdensome. Yet, evidence-based guidelines recommend SET over home-based exercise for PAD. Walking exercise is first line therapy to improve walking distance for PAD, but it does not eliminate ischemic leg symptoms in most people with PAD. The investigators' work and that of others showed that nitrate-rich beetroot juice, which increases plasma nitrite, limb perfusion, and skeletal muscle function, significantly improved exercise tolerance and reduced non-response to exercise in people with and without PAD. The investigators will use a 2 x 2 factorial design to address two major barriers to achieving benefits from exercise therapy for PAD: First, guideline recommendations for supervised exercise therapy (SET) as first line therapy for PAD. Second, the inability of exercise therapy to eliminate PAD-related disability in most people with PAD. Participants will be randomized to one of four groups for 12 weeks: Supervised treadmill exercise + nitrate rich beetroot juice; supervised treadmill exercise + placebo, home-based walking exercise + nitrate rich beetroot juice, home-based walking exercise + placebo.

A vizsgálat 4 csoportja

  • Supervised treadmill exercise + nitrate rich beetroot juiceA vizsgált kezelés

    This group will be participating in Supervised Treadmill Exercise and drinking nitrate rich beetroot juice for 12 weeks.

    Kezelés: Supervised Treadmill Exercise és Nitrate-rich beetroot Juice

  • Supervised treadmill exercise + placeboPlacebo, összehasonlításként

    This group will be participating in Supervised Treadmill Exercise and drinking placebo beetroot juice with nitrate removed for 12 weeks.

    Kezelés: Supervised Treadmill Exercise

  • Home-based walking exercise + nitrate rich beetroot juiceA vizsgált kezelés

    This group will be participating in Home-Based Exercise and drinking nitrate rich beetroot juice for 12 weeks.

    Kezelés: Home-Based Exercise és Nitrate-rich beetroot Juice

  • Home-based walking exercise + placeboPlacebo, összehasonlításként

    This group will be participating in Home-Based Exercise and drinking placebo beetroot juice with nitrated removed for 12 weeks.

    Kezelés: Home-Based Exercise

Következő lépések

Az orvosodnak

Kérdőlap az orvosnak

PDF az orvosodnak: mit vizsgál a vizsgálat, ki vehet részt, és 2 kérdés a részvételi feltételekről, hellyel a válaszoknak és a jegyzeteknek.

A PDF letöltése

PDF, US Letter, 1–2 oldal. A4 méretben

A vizsgálati csapatnak

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Sequential Multiple Assessment Randomized Trial of Exercise for PAD: SMART Exercise for Peripheral Artery Disease: The SMART PAD Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
Kérdések a feltételekről
Forrás: NCT06032065: ki vehet részt
Publikációk
A regiszteradat frissítve
2026. április 15.